Galmed Pharmaceuticals (GLMD) Non-Current Assets (2013 - 2025)

Galmed Pharmaceuticals' Non-Current Assets history runs 13 years deep, the most recent figure standing at $1.9 million for Q3 2025.

• In Q3 2025, Non-Current Assets fell 43.03% year-over-year to $1.9 million; the TTM figure through Dec 2025 stood at $1.1 million (down 54.08% YoY), while the FY2024 annual figure was $2.4 million, down 29.91% from the prior year.
• Non-Current Assets was $1.9 million for Q3 2025 at Galmed Pharmaceuticals, roughly flat from $1.9 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $3.5 million in Q2 2023 to a low of $391000.0 in Q3 2022.
• Historically, Non-Current Assets has averaged $1.9 million across 5 years, with a median of $1.9 million in 2025.
• The sharpest annual moves came in 2021 and 2023: Non-Current Assets tumbled 99.9% in 2021, then jumped 779.8% in 2023.
• A 5-year view of Non-Current Assets shows it stood at $551000.0 in 2021, then soared by 233.39% to $1.8 million in 2022, then jumped by 84.54% to $3.4 million in 2023, then dropped by 29.91% to $2.4 million in 2024, then retreated by 21.72% to $1.9 million in 2025.
• The last three Non-Current Assets figures came in at $1.9 million (Q3 2025), $1.9 million (Q2 2025), and $2.4 million (Q1 2025), per Business Quant data.